Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04967508
Brief Title: A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis

First Submitted : July 8, 2021
First Submitted that Met QC Criteria : July 8, 2021
First Posted : July 19, 2021

Last Update Submitted that Met QC Criteria : April 13, 2022
Last Update Posted : April 15, 2022